Results 151 to 160 of about 93,702 (291)

Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug Use

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1371-1381, May 2026.
The World Health Organization Model Essential Medicines List and African national essential medicines lists (EMLs) detail drugs intended to be consistently available within national health systems, thereby supporting clinicians and pharmacists in making evidence‐based treatment decisions.
Tinashe A. Mazhindu   +5 more
wiley   +1 more source

The Burden of Adverse Drug Reactions in Africa in the Context of Pharmacogenetics‐Based Clinical Guidelines

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1382-1390, May 2026.
Genetic variation has a significant impact on patients' response to medicines. Variations in important pharmacogenes have been evaluated in several studies and consequently led to international guidelines from clinical pharmacogenomics consortia. However, there are limited examples of these being implemented across the African continent despite the ...
Janine Scholefield   +5 more
wiley   +1 more source

Bone Targeting Peptide–Calcium Coordination Complexes for the Treatment of Osteoporosis

open access: yesFood Frontiers, Volume 7, Issue 3, May 2026.
ABSTRACT Current calcium supplement strategies focus on bone‐targeted delivery to reduce bone loss or enhance bone formation. However, peptide–calcium complexes generally lack clear cell selectivity. This study demonstrated that pea peptides (PP), which were rich in aspartic acid (Asp) and glutamic acid (Glu) residues, had the potential to regulate ...
Mengqi Jian   +6 more
wiley   +1 more source

Simvastatin enhances bone formation around titanium implants in rat tibiae [PDF]

open access: bronze, 2009
Yasunori Ayukawa   +7 more
openalex   +1 more source

Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials

open access: yesActa Psychiatrica Scandinavica, Volume 153, Issue 5, Page 402-431, May 2026.
ABSTRACT Background Schizophrenia is characterized by positive, negative, and cognitive symptoms. Current pharmacological treatments often fail to address cognitive deficits. In this review of clinical trials, we aim to identify studies that explore neurobiological (non‐psychological) strategies to address Cognitive Impairment Associated with ...
Bahareh Peyrovian   +3 more
wiley   +1 more source

The impact of simvastatin on warfarin disposition and dose requirements [PDF]

open access: bronze, 2006
Elizabeth Sconce   +4 more
openalex   +1 more source

Cumulative effect of simvastatin, l-arginine, and tetrahydrobiopterin on cerebral blood flow and cognitive function in Alzheimer’s disease [PDF]

open access: gold, 2022
Elizabeth DeGrush   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy